President
Neurodon LLC
Chicago
United States of America
Tel: 219-315-4914
Dr. Russell Dahl is CEO, President, and Founder of Neurodon LLC. Neurodon is developing breakthrough therapies for Alzheimer’s and Parkinson’s disease,having recently discovered small molecules that show efficacy in animal models for both diseases. In addition to his leadership at Neurodon, Dr. Dahl also currently serves as a Director of a specialty biotechnology company in New York and a consulting Global Vice President of an international drug discovery company in China. Previously, Dr. Dahl led all small molecule drug discovery efforts for Celladon Corporation, a clinical-stage public biotechnology company. Prior to his pursuit of entrepreneurial drug discovery, Dr. Dahl held multiple leadership roles in Big Pharma, including stints at DuPont Pharmaceuticals, Bristol-Myers Squibb, and Vertex Pharmaceuticals.
